Ποια είναι η κεφαλαιοποίηση αγοράς για Shanghai Haohai Biological Technology Co., Ltd. (688366)

Η κεφαλαιοποίηση αγοράς για Shanghai Haohai Biological Technology Co., Ltd. (688366) είναι $835.72M

Shanghai Haohai Biological Technology Co., Ltd. (688366) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για Shanghai Haohai Biological Technology Co., Ltd. (688366)

Η τιμή για Shanghai Haohai Biological Technology Co., Ltd. (688366) είναι $4.39

Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and distribution of advanced biomedical materials. Its operations span Mainland China, the United States, the United Kingdom, and various international markets. The company's extensive product portfolio serves multiple medical fields. For ophthalmology, offerings include intraocular lenses, ophthalmic viscoelastic devices, specialized orthokeratology and phakic refractive lenses, eye drops, injectors, and surgical scalpels. In orthopedics, they provide sodium hyaluronate injections and medical chitosan. Their wound care segment features recombinant human epidermal growth factor, effective in treating a broad spectrum of injuries, including burns, residual wounds, donor site trauma, post-traumatic wounds, and both acute and chronic ulcerations. Anti-adhesion solutions are offered in the form of medical sodium hyaluronate gel and medical chitosan, while hemostatic products include collagen sponges and porcine fibrin sealants. Within medical aesthetics, Shanghai Haohai produces a diverse range of hyaluronic acid (HA) dermal fillers: Matrifill, a first-generation mono-phase injectable gel; Janlane, a second-generation filler engineered for dynamic applications; and Hyalumatrix, a third-generation product designed for precise aesthetic enhancements. This division also supplies radio frequency devices and laser equipment. Beyond its core product offerings, the company actively pursues research and development in biological engineering and pharmaceutical innovations. It also provides related technology transfer and consultation services, alongside engaging in investment and trading activities. Originally established in 2007 as Haohai Limited, the company adopted its current name, Shanghai Haohai Biological Technology Co., Ltd., in 2010 and is headquartered in Shanghai, China.

Η τιμή για 688366	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$27,674.89 $835.72M	NVDA	$5.264T	+629,763.82%
$24,717.05 $835.72M	AAPL	$4.701T	+562,445.22%
$21,961.59 $835.72M	GOOG	$4.177T	+499,732.69%
$20,070.06 $835.72M	MSFT	$3.817T	+456,682.54%
$15,069.82 $835.72M	AMZN	$2.866T	+342,880.10%

Η τιμή για 688366

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$27,674.89 $835.72M